C4 Therapeutics, Inc. · NASDAQ:CCCC
Point72 Asset Management, L.P.'s stake in C4 Therapeutics, Inc. fell to 0.20% (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Point72 Asset Management, L.P.'s stake in C4 Therapeutics, Inc. fell to 0.20%, 169,096 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 0.20%
- Shares
- 169,096
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Point72 Asset Management, L.P. | 0.20% | 169,096 |
| Point72 Capital Advisors, Inc. | 0.20% | 169,096 |
| Steven A. Cohen | 0.20% | 169,096 |
Source
Related
- C4 Therapeutics, Inc.
- Point72 Asset Management, L.P.
- C4 Therapeutics, Inc. shareholders
- Schedule 13G · Point72 Asset Management, L.P. · Oct 20, 2025
- Form 4 · Anderson Kenneth Carl · Oct 2, 2026
- Form 4 · Grogan Donna Roy · Oct 2, 2026
- Form 4 · Adams Kendra · Sep 21, 2026
- Schedule 13G/A · Lynx1 Capital Management LP · Aug 14, 2026
- Schedule 13G/A · Squadron Capital Management LLC · Aug 14, 2026